294 related articles for article (PubMed ID: 24500660)
1. Call for a dedicated European legal framework for bacteriophage therapy.
Verbeken G; Pirnay JP; Lavigne R; Jennes S; De Vos D; Casteels M; Huys I
Arch Immunol Ther Exp (Warsz); 2014 Apr; 62(2):117-29. PubMed ID: 24500660
[TBL] [Abstract][Full Text] [Related]
2. Optimizing the European regulatory framework for sustainable bacteriophage therapy in human medicine.
Verbeken G; Pirnay JP; De Vos D; Jennes S; Zizi M; Lavigne R; Casteels M; Huys I
Arch Immunol Ther Exp (Warsz); 2012 Jun; 60(3):161-72. PubMed ID: 22527355
[TBL] [Abstract][Full Text] [Related]
3. Taking bacteriophage therapy seriously: a moral argument.
Verbeken G; Huys I; Pirnay JP; Jennes S; Chanishvili N; Scheres J; Górski A; De Vos D; Ceulemans C
Biomed Res Int; 2014; 2014():621316. PubMed ID: 24868534
[TBL] [Abstract][Full Text] [Related]
4. Access to bacteriophage therapy: discouraging experiences from the human cell and tissue legal framework.
Verbeken G; Huys I; De Vos D; De Coninck A; Roseeuw D; Kets E; Vanderkelen A; Draye JP; Rose T; Jennes S; Ceulemans C; Pirnay JP
FEMS Microbiol Lett; 2016 Feb; 363(4):. PubMed ID: 26678555
[TBL] [Abstract][Full Text] [Related]
5. Bacteriophage applications: where are we now?
Monk AB; Rees CD; Barrow P; Hagens S; Harper DR
Lett Appl Microbiol; 2010 Oct; 51(4):363-9. PubMed ID: 20796209
[TBL] [Abstract][Full Text] [Related]
6. European regulatory aspects of phage therapy: magistral phage preparations.
Verbeken G; Pirnay JP
Curr Opin Virol; 2022 Feb; 52():24-29. PubMed ID: 34801778
[TBL] [Abstract][Full Text] [Related]
7. [Bacteriophages as antibacterial agents].
Shasha SM; Sharon N; Inbar M
Harefuah; 2004 Feb; 143(2):121-5, 166. PubMed ID: 15143702
[TBL] [Abstract][Full Text] [Related]
8. Bacteriophage therapy: an overview and the position of Italian Society of Infectious and Tropical Diseases.
Cesta N; Di Luca M; Corbellino M; Tavio M; Galli M; Andreoni M
Infez Med; 2020 Sep; 28(3):322-331. PubMed ID: 32920567
[TBL] [Abstract][Full Text] [Related]
9. Bacteriophages: an appraisal of their role in the treatment of bacterial infections.
Hanlon GW
Int J Antimicrob Agents; 2007 Aug; 30(2):118-28. PubMed ID: 17566713
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic bacteriophages as a rescue treatment for drug-resistant infections - an in vivo studies overview.
Kwiatek M; Parasion S; Nakonieczna A
J Appl Microbiol; 2020 Apr; 128(4):985-1002. PubMed ID: 31778593
[TBL] [Abstract][Full Text] [Related]
11. A bacteriophage journey at the European Medicines Agency.
Debarbieux L; Pirnay JP; Verbeken G; De Vos D; Merabishvili M; Huys I; Patey O; Schoonjans D; Vaneechoutte M; Zizi M; Rohde C
FEMS Microbiol Lett; 2016 Jan; 363(2):fnv225. PubMed ID: 26656541
[TBL] [Abstract][Full Text] [Related]
12. Bacteriophages as Therapeutic and Prophylactic Means: Summary of the Soviet and Post Soviet Experiences.
Chanishvili N
Curr Drug Deliv; 2016; 13(3):309-23. PubMed ID: 27090515
[TBL] [Abstract][Full Text] [Related]
13. The Medicinal Phage-Regulatory Roadmap for Phage Therapy under EU Pharmaceutical Legislation.
Faltus T
Viruses; 2024 Mar; 16(3):. PubMed ID: 38543808
[TBL] [Abstract][Full Text] [Related]
14. Bacteriophage therapy: a potential solution for the antibiotic resistance crisis.
Golkar Z; Bagasra O; Pace DG
J Infect Dev Ctries; 2014 Feb; 8(2):129-36. PubMed ID: 24518621
[TBL] [Abstract][Full Text] [Related]
15. European regulatory conundrum of phage therapy.
Verbeken G; De Vos D; Vaneechoutte M; Merabishvili M; Zizi M; Pirnay JP
Future Microbiol; 2007 Oct; 2(5):485-91. PubMed ID: 17927471
[TBL] [Abstract][Full Text] [Related]
16. Bacteriophage therapy as an alternative treatment for human infections. A comprehensive review.
Kakasis A; Panitsa G
Int J Antimicrob Agents; 2019 Jan; 53(1):16-21. PubMed ID: 30236954
[TBL] [Abstract][Full Text] [Related]
17. Bacteriophages as therapeutic agents.
Sulakvelidze A; Morris JG
Ann Med; 2001 Nov; 33(8):507-9. PubMed ID: 11730156
[TBL] [Abstract][Full Text] [Related]
18. The next generation of bacteriophage therapy.
Lu TK; Koeris MS
Curr Opin Microbiol; 2011 Oct; 14(5):524-31. PubMed ID: 21868281
[TBL] [Abstract][Full Text] [Related]
19. Bacteriophage therapy for challenging bacterial infections: achievements, limitations and prospects for future clinical use by veterinary dermatologists.
Squires RA
Vet Dermatol; 2021 Dec; 32(6):587-e158. PubMed ID: 33870572
[TBL] [Abstract][Full Text] [Related]
20. [The potential use of bacteriophages in view of the current antibiotic therapy crisis].
Borysowski J; Weber-Dabrowska B; Górski A
Pol Arch Med Wewn; 2005 Jan; 113(1):73-8. PubMed ID: 16130605
[No Abstract] [Full Text] [Related]
[Next] [New Search]
